Enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes in the presence of fluvoxamine.
about
Enantiomeric separation of proton pump inhibitors on new generation chiral columns using LC and supercritical fluid chromatography.Enantioselective disposition of rabeprazole in relation to CYP2C19 genotypesPharmacogenetics of drug-drug interaction and drug-drug-gene interaction: a systematic review on CYP2C9, CYP2C19 and CYP2D6.Impact of genetic polymorphism on drug-drug interactions mediated by cytochromes: a general approach.Clinical pharmacokinetics of fexofenadine enantiomers.In vivo quantitative prediction of the effect of gene polymorphisms and drug interactions on drug exposure for CYP2C19 substratesPersonalized drug therapy; the genome, the chip and the physician.Influence of CYP2C19 and ABCB1 polymorphisms on plasma concentrations of lansoprazole enantiomers after enteral administration.Impact of CYP2C9 polymorphisms on the vulnerability to pharmacokinetic drug-drug interactions during acenocoumarol treatment.Intestinal CYP3A4 is not involved in the enantioselective disposition of lansoprazole.Effects of diltiazem on pharmacokinetics of tacrolimus in relation to CYP3A5 genotype status in renal recipients: from retrospective to prospective.
P2860
Q34822438-DF5F6D75-D207-41F4-8021-DF045EA86900Q35827444-9C9B4268-56CA-4671-996A-1A4EF03E083BQ36365500-8406111E-55E2-4229-9B8D-B642C0E23A3CQ37207816-80657DD5-56C8-4B79-BC4B-ACF225606A47Q37641373-D85EB7B9-5F14-48DE-BF4F-768EE80F638DQ41986948-826A9A13-6428-46E6-A705-74FDD1A8893CQ42758765-FF77A849-630C-41A6-8ED4-90F5E65468A1Q43042883-97EA867F-ED91-462D-8F5C-924B22291F8BQ46702584-72FEF3E1-7CE6-4D1C-B968-75CB14C63C46Q46968571-B53F24C1-BEA5-496C-8B42-484CCE9C44E9Q51693404-DEBCBA3F-65CD-4B1F-B777-45F86AB3986C
P2860
Enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes in the presence of fluvoxamine.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Enantioselective disposition o ...... n the presence of fluvoxamine.
@ast
Enantioselective disposition o ...... n the presence of fluvoxamine.
@en
type
label
Enantioselective disposition o ...... n the presence of fluvoxamine.
@ast
Enantioselective disposition o ...... n the presence of fluvoxamine.
@en
prefLabel
Enantioselective disposition o ...... n the presence of fluvoxamine.
@ast
Enantioselective disposition o ...... n the presence of fluvoxamine.
@en
P2093
P2860
P1476
Enantioselective disposition o ...... n the presence of fluvoxamine.
@en
P2093
Hitoshi Tada
Kazunobu Sugawara
Masatomo Miura
Tomonori Tateishi
Toshio Suzuki
Tsukasa Uno
P2860
P356
10.1111/J.1365-2125.2005.02381.X
P407
P577
2005-07-01T00:00:00Z